NO166687C - Fremgangsmaate for fremstilling av en stabil, vandig, injiserbar opploesning av piroxicam. - Google Patents

Fremgangsmaate for fremstilling av en stabil, vandig, injiserbar opploesning av piroxicam.

Info

Publication number
NO166687C
NO166687C NO854011A NO854011A NO166687C NO 166687 C NO166687 C NO 166687C NO 854011 A NO854011 A NO 854011A NO 854011 A NO854011 A NO 854011A NO 166687 C NO166687 C NO 166687C
Authority
NO
Norway
Prior art keywords
piroxicam
stable
aqueous
procedure
preparation
Prior art date
Application number
NO854011A
Other languages
English (en)
Norwegian (no)
Other versions
NO166687B (no
NO854011L (no
Inventor
Walter Fries
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of NO854011L publication Critical patent/NO854011L/no
Publication of NO166687B publication Critical patent/NO166687B/no
Publication of NO166687C publication Critical patent/NO166687C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Finger-Pressure Massage (AREA)
NO854011A 1984-10-10 1985-10-09 Fremgangsmaate for fremstilling av en stabil, vandig, injiserbar opploesning av piroxicam. NO166687C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843437232 DE3437232A1 (de) 1984-10-10 1984-10-10 Stabilisierte injektionsloesungen von piroxicam

Publications (3)

Publication Number Publication Date
NO854011L NO854011L (no) 1986-04-11
NO166687B NO166687B (no) 1991-05-21
NO166687C true NO166687C (no) 1991-09-04

Family

ID=6247603

Family Applications (1)

Application Number Title Priority Date Filing Date
NO854011A NO166687C (no) 1984-10-10 1985-10-09 Fremgangsmaate for fremstilling av en stabil, vandig, injiserbar opploesning av piroxicam.

Country Status (22)

Country Link
US (1) US4628053A (fr)
EP (1) EP0177870B1 (fr)
JP (1) JPS6191116A (fr)
KR (1) KR890001001B1 (fr)
CN (1) CN85107838B (fr)
AT (1) ATE62416T1 (fr)
AU (1) AU557184B2 (fr)
CA (1) CA1251734A (fr)
DD (1) DD238329A5 (fr)
DE (2) DE3437232A1 (fr)
DK (1) DK165901C (fr)
FI (1) FI84315C (fr)
GR (1) GR852439B (fr)
HU (1) HU195111B (fr)
IE (1) IE58267B1 (fr)
IL (1) IL76624A0 (fr)
NO (1) NO166687C (fr)
NZ (1) NZ213758A (fr)
PH (1) PH23058A (fr)
PT (1) PT81264B (fr)
SU (1) SU1482509A3 (fr)
ZA (1) ZA857783B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545910B1 (fr) * 1983-05-11 1988-07-22 Valeo Dispositif pour ameliorer l'efficacite d'un echangeur de chaleur dans un boitier d'une installation de climatisation, et boitier de cette installation
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1998001138A1 (fr) * 1996-07-04 1998-01-15 Nippon Kayaku Kabushiki Kaisha Injections de succinate sodique de methylprednisolone
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8314124B2 (en) * 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
EP1568369A1 (fr) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Utilisation du meloxicam pour le traitement de maladies respiratoires des porcs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
BRPI0617208A2 (pt) * 2005-09-30 2011-07-19 Boehringer Ingelheim Vetmed preparação farmacêutica contendo meloxicam
EP1937642B1 (fr) * 2005-10-19 2014-09-10 Teva Pharmaceutical Industries Ltd Cristaux de sodium de laquinimod, et procede de fabrication de ceux-ci
WO2007146248A2 (fr) * 2006-06-12 2007-12-21 Teva Pharmaceutical Industries, Ltd. Préparations de laquinimod stables
ES2600920T3 (es) 2007-12-20 2017-02-13 Teva Pharmaceutical Industries, Ltd. Preparaciones estables de laquinimod
AU2009288108B2 (en) * 2008-09-03 2013-10-17 Teva Pharmaceutical Industries, Ltd. 2-oxo-1,2-dihydro-quinoline modulators of immune function
JP5359333B2 (ja) * 2009-02-05 2013-12-04 ゼリア新薬工業株式会社 コロソリン酸含有水性液剤
HUE027680T2 (en) * 2009-07-30 2016-11-28 Teva Pharma Treatment of Crohn's disease with laquinimod
PL3064206T3 (pl) * 2009-08-10 2020-02-28 Active Biotech Ab Leczenie choroby Huntingtona z zastosowaniem lakwinimodu
DK2488145T3 (da) 2009-10-12 2024-07-22 Boehringer Ingelheim Vetmedica Gmbh Beholdere til sammensætninger omfattende meloxicam
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
MX2012010077A (es) 2010-03-03 2012-09-12 Boehringer Ingelheim Vetmed Uso de meloxicam para el tratamiento a largo plazo de trastornos musculoesqueleticos en gatos.
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
CN106344576A (zh) 2011-10-12 2017-01-25 泰华制药工业有限公司 以拉喹莫德和芬戈莫德的组合治疗多发性硬化症
CN104093310A (zh) 2012-02-03 2014-10-08 泰华制药工业有限公司 拉喹莫德用于治疗一线抗TNFα疗法失败的克罗恩氏病患者的用途
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
EP2916915A4 (fr) 2012-11-07 2016-06-22 Teva Pharma Sels d'amine de laquinimod
MX2015011627A (es) 2013-03-14 2016-05-16 Teva Pharma Cristales de laquinimod sodico y proceso mejorado para la elaboracion de los mismos.
KR101749425B1 (ko) * 2015-11-17 2017-06-22 연세대학교 산학협력단 난용성 약물의 서방형 제제
CA3072335A1 (fr) * 2017-08-09 2019-02-14 Piedmont Animal Health Inc. Formulations therapeutiques et leurs utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (fr) * 1967-05-18 1900-01-01
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung

Also Published As

Publication number Publication date
CN85107838B (zh) 1988-08-24
ATE62416T1 (de) 1991-04-15
NZ213758A (en) 1988-07-28
EP0177870A2 (fr) 1986-04-16
HU195111B (en) 1988-04-28
AU4842185A (en) 1986-04-17
ZA857783B (en) 1987-05-27
PT81264B (pt) 1988-02-17
KR860003013A (ko) 1986-05-19
CA1251734A (fr) 1989-03-28
DD238329A5 (de) 1986-08-20
PT81264A (en) 1985-11-01
DE3437232A1 (de) 1986-04-17
CN85107838A (zh) 1986-07-09
DK461385D0 (da) 1985-10-09
FI853926L (fi) 1986-04-11
IL76624A0 (en) 1986-02-28
DK461385A (da) 1986-04-11
US4628053A (en) 1986-12-09
DE3582468D1 (de) 1991-05-16
AU557184B2 (en) 1986-12-11
KR890001001B1 (ko) 1989-04-18
IE852483L (en) 1986-04-10
JPS6191116A (ja) 1986-05-09
HUT38541A (en) 1986-06-30
EP0177870B1 (fr) 1991-04-10
NO166687B (no) 1991-05-21
DK165901B (da) 1993-02-08
SU1482509A3 (ru) 1989-05-23
GR852439B (fr) 1986-02-10
JPH03849B2 (fr) 1991-01-09
FI853926A0 (fi) 1985-10-09
NO854011L (no) 1986-04-11
PH23058A (en) 1989-03-27
IE58267B1 (en) 1993-08-25
EP0177870A3 (en) 1987-06-03
FI84315C (fi) 1991-11-25
DK165901C (da) 1993-06-28
FI84315B (fi) 1991-08-15

Similar Documents

Publication Publication Date Title
NO166687C (no) Fremgangsmaate for fremstilling av en stabil, vandig, injiserbar opploesning av piroxicam.
DE3688114D1 (de) Inklusionskomplexe von 7-isopropoxy-isoflavon mit cyclodextrinen, verfahren zu deren herstellung und diese inklusionskomplexe enthaltende pharmazeutische praeparate.
SE8402560L (sv) Farmaceutisk komposition
SE8505112D0 (sv) Novel pharmacological compounds
IT1200589B (it) Derivati naturali attivita farmagologica
LV10954A (lv) Benzimidazola atvasinajumi to iegusanas panemiens un tos saturosa farmaceitiska kompozicija
FI940696A0 (fi) Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö
BG100069A (en) Amidine derivatives containing heterocylic groups, their preparation and application
IL100805A0 (en) Benzyloxyphenyl derivatives,their preparation and pharmaceutical compositions containing them
FR2607502B1 (fr) Derives de l'imidazole, leur preparation et compositions medicamenteuses les contenant
SE8600658D0 (sv) Novel composition of matter
ATE48993T1 (de) Aetheroxidderivate von zyklopropylphenolen.
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
SE8204792L (sv) N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt
FR2600065B1 (fr) Nouveaux derives de l'acide 5-((2-benzofuranyl) carbonyl) thiophene acetique, leurs sels, leurs procedes de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
GB985773A (en) Improvements in or relating to coated medicinals
ATE1011T1 (de) 5-fluoruracil-derivate, deren herstellung und ihre pharmazeutischen zusammensetzungen.